Cotemporary DES paired with FFR guidance and modern medical therapy may be what narrowed the gap, William Fearon says.

In sharp contrast to earlier studies, patients with severe triple-vessel heart disease fared equally well whether they ...

Biotechnology firm Humacyte’s (HUMA) shares have declined since the company presented its fourth-quarter and full-year 2024 results. The ...

In sharp contrast to earlier studies, patients with severe triple-vessel heart disease fared equally well whether they underwent open-heart bypass surgery (CABG) or a less invasive procedure called ...

Compared with other studies, the differences in outcomes between percutaneous coronary intervention (PCI) and coronary artery ...

Coronary artery bypass grafting is a more invasive procedure where surgeons use blood vessels from another part of the body ...

A Sunderland dad died weeks after a hospital error meant he went a week without vital medication after undergoing heart ...

FDA Approval: The FDA granted full approval for Symvess on December 19, 2024 for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid ...

Background Cardiac surgery carries a heightened risk of bradyarrhythmias, but current permanent pacemaker (PPM) implantation ...

Lupin Digital Health (LDH), India's leading evidence-based Digital Therapeutics (DTx) platform, today announced the launch of ...

Five WVU Medicine hospitals have been recognized in Castle Connolly's inaugural Top Hospitals awards for their excellence in ...

Lupin Digital Health has launched a Post-Procedure Home-Based Care Guide, developed alongside the American College of ...